Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.
about
How do we reduce plasma transfusion in Rhode Island?ADAMTS13 test and/or PLASMIC clinical score in management of acquired thrombotic thrombocytopenic purpura: a cost-effective analysis.Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.External validation of the PLASMIC score: a clinical prediction tool for thrombotic thrombocytopenic purpura diagnosis and treatment.
P2860
Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Treatment with or without plas ...... ropensity score-matched study.
@ast
Treatment with or without plas ...... ropensity score-matched study.
@en
type
label
Treatment with or without plas ...... ropensity score-matched study.
@ast
Treatment with or without plas ...... ropensity score-matched study.
@en
prefLabel
Treatment with or without plas ...... ropensity score-matched study.
@ast
Treatment with or without plas ...... ropensity score-matched study.
@en
P2093
P2860
P356
P1433
P1476
Treatment with or without plas ...... ropensity score-matched study.
@en
P2093
Christopher P Stowell
Pavan K Bendapudi
Richard M Kaufman
Robert S Makar
Shelley Hurwitz
Walter S Dzik
P2860
P304
P356
10.1111/TRF.13654
P577
2016-05-27T00:00:00Z